‘Major blunder:’ Ex-staffers blast Bristol Myers Squibb’s handling of Breyanzi approval in latest CVR lawsuit update fkansteiner Wed, 02/23/2022 – 11:57 More: 'Major blunder:' Ex-staffers blast Bristol Myers Squibb's handling of Breyanzi approval in latest CVR lawsuit update Source: fierce
read moreNovavax begins delivery of its long-delayed COVID-19 vaccine in Europe kdunleavy Wed, 02/23/2022 – 11:14 More: Novavax begins delivery of its long-delayed COVID-19 vaccine in Europe Source: fierce
read moreGearing up for anemia market-grab against GSK—and maybe AZ—Akebia expands Vifor pact with $85M for key launch aliu Wed, 02/23/2022 – 10:42 More: Gearing up for anemia market-grab against GSK—and maybe AZ—Akebia expands Vifor pact with M for key launch
read moreIntellia leases new facility to produce CRISPR-based therapies jkeenan Wed, 02/23/2022 – 10:40 More: Intellia leases new facility to produce CRISPR-based therapies Source: fierce
read moreJohnson & Johnson, Moderna set to face shareholder votes on vaccine pricing strategy, manufacturing tech sharing esagonowsky Wed, 02/23/2022 – 10:27 More: Johnson & Johnson, Moderna set to face shareholder votes on vaccine pricing strategy, manufacturing tech sharing Source: fierce
read moreResearchers discovered that recipients experiencing an allergic response to second COVID vaccine dose are minimal More: Greater tolerance: Allergic reactions to COVID vaccine lower for second dose Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals